References
1. Zhu N, Zhang D, Wang W, Li
X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X,
Wang D, Xu W, Wu G, Gao GF, Tan W. A Novel Coronavirus from Patients
with Pneumonia in China, 2019. N Engl J Med 2020;382:727–733.
2. World Health Organization
. Coronavirus disease 2019 ( COVID-19): situation report, 70. 2020.
https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200330-sitrep-70-covid-19.pdf?sfvrsn=7e0fe3f8_4
.
3. Centers for Disease
Control and Prevention. Coronavirus Disease 2019 (COVID-19) –
Symptoms.
https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
Accessed March 26, 2020.
4. Centers for Disease Control
and Prevention. Coronavirus Disease 2019 (COVID-19).
https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fspecific-groups%2Fhigh-risk-complications.html.
Accessed March 31, 2020.
5. Li B, Yang J, Zhao F, Zhi
L, Wang X, Liu L, Bi Z, Zhao Y. Prevalence and impact of cardiovascular
metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020.
6. Wang D, Hu B, Hu C, Zhu F,
Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X,
Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019
Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.
7. Shi S, Qin M, Shen B, Cai
Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang
C. Association of Cardiac Injury With Mortality in Hospitalized Patients
With COVID-19 in Wuhan, China. JAMA Cardiol 2020.
8. Yao XH, Li TY, He ZC, Ping
YF, Liu HW, Yu SC, Mou HM, Wang LH, Zhang HR, Fu WJ, Luo T, Liu F, Chen
C, Xiao HL, Guo HT, Lin S, Xiang DF, Shi Y, Li QR, Huang X, Cui Y, Li
XZ, Tang W, Pan PF, Huang XQ, Ding YQ, Bian XW. A pathological report of
three COVID-19 cases by minimally invasive autopsies. Zhonghua Bing Li
Xue Za Zhi 2020;49:E009.
9. Lippi G, Plebani M.
Laboratory abnormalities in patients with COVID-2019 infection. Clin
Chem Lab Med 2020.
10. Fung G, Luo H, Qiu Y,
Yang D, McManus B. Myocarditis. Circ Res 2016;118:496–514.
11. Elkind MSV. Why now?
Moving from stroke risk factors to stroke triggers. Curr Opin Neurol
2007;20:51–57.
12. Smeeth L, Thomas SL, Hall
AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction
and stroke after acute infection or vaccination. N Engl J Med
2004;351:2611–2618.
13. Zheng Y-Y, Ma Y-T, Zhang
J-Y, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol
2020.
14. Hoffmann M, Kleine-Weber
H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler
G, Wu N-H, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 Cell
Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven
Protease Inhibitor. Cell 2020.
15. American Heart
Associatin. HFSA/ACC/AHA statement addresses concerns re: using RAAS
antagonists in COVID-19.
https://professional.heart.org/professional/ScienceNews/UCM_505836_HFSAACCAHAstatement-addresses-concerns-re-using-RAAS-antagonists-in-COVID.jsp.
Accessed March 28, 2020.
16. Kuster GM, Pfister O,
Burkard T, Zhou Q, Twerenbold R, Haaf P, Widmer AF, Osswald S.
SARS-CoV2: should inhibitors of the renin-angiotensin system be
withdrawn in patients with COVID-19? Eur Heart J 2020.
17. Vaduganathan M, Vardeny
O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD.
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with
Covid-19. N Engl J Med 2020.
18. Alhogbani T. Acute
myocarditis associated with novel Middle east respiratory syndrome
coronavirus. Ann Saudi Med 2016;36:78–80.
19. Inciardi RM, Lupi L,
Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D,
Gavazzi E, Maroldi R, Adamo M, Ammirati E, Sinagra G, Lombardi CM, Metra
M. Cardiac Involvement in a Patient With Coronavirus Disease 2019
(COVID-19). JAMA Cardiol 2020.
20. Huang C, Wang Y, Li X,
Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J,
Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J,
Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of
patients infected with 2019 novel coronavirus in Wuhan, China. Lancet
2020;395:497–506.
21. Cui Y, Tian M, Huang D,
Wang X, Huang Y, Fan L, Wang L, Chen Y, Liu W, Zhang K, Wu Y, Yang Z,
Tao J, Feng J, Liu K, Ye X, Wang R, Zhang X, Zha Y. A 55-Day-Old Female
Infant infected with COVID 19: presenting with pneumonia, liver injury,
and heart damage. J Infect Dis 2020.
22. Sakabe M, Yoshioka R,
Fujiki A. Sick sinus syndrome induced by interferon and ribavirin
therapy in a patient with chronic hepatitis C. J Cardiol Cases
2013;8:173–175.
23. Wu Q, Zhou L, Sun X, Yan
Z, Hu C, Wu J, Xu L, Li X, Liu H, Yin P, Li K, Zhao J, Li Y, Wang X, Li
Y, Zhang Q, Xu G, Chen H. Altered Lipid Metabolism in Recovered SARS
Patients Twelve Years after Infection. Sci Rep 2017;7:9110.